Literature DB >> 33031527

Antigenic cells augment CAR T cells.

Pamela J Skinner1.   

Abstract

Entities:  

Year:  2020        PMID: 33031527      PMCID: PMC7544542          DOI: 10.1182/blood.2020007761

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  7 in total

1.  Robust expansion of HIV CAR T cells following antigen boosting in ART-suppressed nonhuman primates.

Authors:  Blake J Rust; Leslie S Kean; Lucrezia Colonna; Katherine E Brandenstein; Nikhita H Poole; Willimark Obenza; Mark R Enstrom; Colby R Maldini; Gavin I Ellis; Christine M Fennessey; Meei-Li Huang; Brandon F Keele; Keith R Jerome; James L Riley; Hans-Peter Kiem; Christopher W Peterson
Journal:  Blood       Date:  2020-10-08       Impact factor: 22.113

Review 2.  Chimeric antigen receptor T-cell approaches to HIV cure.

Authors:  Anne-Sophie Kuhlmann; Christopher W Peterson; Hans-Peter Kiem
Journal:  Curr Opin HIV AIDS       Date:  2018-09       Impact factor: 4.283

Review 3.  Quarter Century of Anti-HIV CAR T Cells.

Authors:  Thor A Wagner
Journal:  Curr HIV/AIDS Rep       Date:  2018-04       Impact factor: 5.071

4.  Defining total-body AIDS-virus burden with implications for curative strategies.

Authors:  Jacob D Estes; Cissy Kityo; Francis Ssali; Louise Swainson; Krystelle Nganou Makamdop; Gregory Q Del Prete; Steven G Deeks; Paul A Luciw; Jeffrey G Chipman; Gregory J Beilman; Torfi Hoskuldsson; Alexander Khoruts; Jodi Anderson; Claire Deleage; Jacob Jasurda; Thomas E Schmidt; Michael Hafertepe; Samuel P Callisto; Hope Pearson; Thomas Reimann; Jared Schuster; Jordan Schoephoerster; Peter Southern; Katherine Perkey; Liang Shang; Stephen W Wietgrefe; Courtney V Fletcher; Jeffrey D Lifson; Daniel C Douek; Joseph M McCune; Ashley T Haase; Timothy W Schacker
Journal:  Nat Med       Date:  2017-10-02       Impact factor: 53.440

5.  PD-1 blockade induces responses by inhibiting adaptive immune resistance.

Authors:  Paul C Tumeh; Christina L Harview; Jennifer H Yearley; I Peter Shintaku; Emma J M Taylor; Lidia Robert; Bartosz Chmielowski; Marko Spasic; Gina Henry; Voicu Ciobanu; Alisha N West; Manuel Carmona; Christine Kivork; Elizabeth Seja; Grace Cherry; Antonio J Gutierrez; Tristan R Grogan; Christine Mateus; Gorana Tomasic; John A Glaspy; Ryan O Emerson; Harlan Robins; Robert H Pierce; David A Elashoff; Caroline Robert; Antoni Ribas
Journal:  Nature       Date:  2014-11-27       Impact factor: 49.962

Review 6.  Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations.

Authors:  Jun Gong; Alexander Chehrazi-Raffle; Srikanth Reddi; Ravi Salgia
Journal:  J Immunother Cancer       Date:  2018-01-23       Impact factor: 13.751

7.  Enhancing SIV-specific immunity in vivo by PD-1 blockade.

Authors:  Vijayakumar Velu; Kehmia Titanji; Baogong Zhu; Sajid Husain; Annette Pladevega; Lilin Lai; Thomas H Vanderford; Lakshmi Chennareddi; Guido Silvestri; Gordon J Freeman; Rafi Ahmed; Rama Rao Amara
Journal:  Nature       Date:  2008-12-10       Impact factor: 49.962

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.